Wang, Xiaowei
- University of Illinois at Chicago · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #24,270
- Rising Star
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2010 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$498.8K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#24,270
By linked amount among FY2023 PIs
Earliest Year Loaded
2010
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Wang, Xiaowei as a PI. Multi-PI records show the full award amount for context.
- 5R35GM141535-03R35Contact PICombined Computational and Experimental Analyses of Gene Regulation by MicroRNAsUniversity of Illinois at Chicago · Pharmacology (NIH department code)$399.8Kaward amount
- 3R35GM141535-03S1R35Contact PICombined Computational and Experimental Analyses of Gene Regulation by MicroRNAsUniversity of Illinois at Chicago · Pharmacology (NIH department code)$99Kaward amount
Award organization
Organizations that administered FY2023 awards listing Wang, Xiaowei as a PI.
FY2023 award administered by University of Illinois at Chicago (IL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2010First NIH AwardUniversity of Illinois at Chicago
- 2011$500K Cumulative Funding
- 2013$1M Cumulative Funding
- 2016$2M Cumulative Funding
- 2018Entered Top 50% NationallyRanked #9348
- 2021$5M Cumulative Funding